The
News Room
Featured Stories
- August 17, 2010
Engagement technologies provide activation
Managed and preventive care is playing an increasingly critical role, as technology is being thrust to the foreground, tracking and enabling care compliance. Technology's potential to enable preventive care and advance the outcomes of managed care, rather than simply being deployed as an administrative tick box, is a force to be acknowledged in the healthcare industry. - July 20, 2010
Delivering, Quite Literally, the Brand Promise
Consumers are increasingly agnostic as to whether they buy their goods in-store, over the phone, or online. Often the only "human" experience a shopper has with a company's brand is in the product delivery. But here's the rub: Mobile and ubiquitous communications mean that customers are now constantly moving targets, and they expect service and delivery to accommodate their schedules. They want a text or a voicemail when a delivery or service appointment is 30 minutes away NOT a delivery window of between four to seven hours. Product and service delivery has not typically been geared around this thinking. It needs to be. - July 7, 2010
TeleVox Partners with ProKarma to Deliver Best-In-Class SEO and SEM Services
TeleVox has partnered with ProKarma to deliver SEO and SEM services that are always on the cutting edge of search and social media. The result of this partnership is BrandAwake, SEO and SEM consulting services powered by ProKarma and developed for and offered exclusively to TeleVox WebPlus clients. - June 7, 2010
Two Practices, Two Solutions
Richard M. Dunn, DDS, and Nicholas J. Savastano, DMD, MS, jointly operate two busy orthodontic practice locations in the Central Florida area (one in Longwood, Fla, and one in Lake Mary, Fla). Dunn has been in practice in the area since 1977, and was joined in 2003 by Savastano after he graduated from Ohio State University. In their offices, patients are not assigned to one particular doctor, and each patient sees both Dunn and Savastano. Overall, Dunn and Savastano have more than 15,000 patients in active treatment, recall, and retention.
